tpa Search Results


  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 99
    Millipore tpa
    Generation of 5-FU sensitive and resistant tumors in a mouse model of chemically-induced carcinogenesis. Carcinogenesis was initiated with <t>DMBA,</t> followed by bi-weekly treatments with <t>TPA</t> to promote tumor growth. Isolated RNA from 2 pairs of 5-FU sensitive and 5-FU resistant tumors was used to perform whole-transcriptome sequencing using Illumina 2000 , in order to identify differentially expressed genes between sensitive and resistant tumors.
    Tpa, supplied by Millipore, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/tpa/product/Millipore
    Average 99 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    tpa - by Bioz Stars, 2021-03
    99/100 stars
      Buy from Supplier

    99
    R&D Systems elisa
    Generation of 5-FU sensitive and resistant tumors in a mouse model of chemically-induced carcinogenesis. Carcinogenesis was initiated with <t>DMBA,</t> followed by bi-weekly treatments with <t>TPA</t> to promote tumor growth. Isolated RNA from 2 pairs of 5-FU sensitive and 5-FU resistant tumors was used to perform whole-transcriptome sequencing using Illumina 2000 , in order to identify differentially expressed genes between sensitive and resistant tumors.
    Elisa, supplied by R&D Systems, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/elisa/product/R&D Systems
    Average 99 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    elisa - by Bioz Stars, 2021-03
    99/100 stars
      Buy from Supplier

    86
    Genentech tpa
    Cortical lesion volume after <t>TBI</t> and <t>tPA</t> treatment. The bar graph shows no significance (NS) in the cortical lesion volume between the TBI+Saline and TBI+tPA groups examined at 35 days post injury ( p > 0.05). Scale bar = 2 mm. Data represent mean ± SD. n = 8 (rats/group).
    Tpa, supplied by Genentech, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/tpa/product/Genentech
    Average 86 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    tpa - by Bioz Stars, 2021-03
    86/100 stars
      Buy from Supplier

    Image Search Results


    Generation of 5-FU sensitive and resistant tumors in a mouse model of chemically-induced carcinogenesis. Carcinogenesis was initiated with DMBA, followed by bi-weekly treatments with TPA to promote tumor growth. Isolated RNA from 2 pairs of 5-FU sensitive and 5-FU resistant tumors was used to perform whole-transcriptome sequencing using Illumina 2000 , in order to identify differentially expressed genes between sensitive and resistant tumors.

    Journal: Data in Brief

    Article Title: Whole transcriptome sequence data of 5-FU sensitive and 5-FU resistant tumors generated in a mouse model of de novo carcinogenesis

    doi: 10.1016/j.dib.2018.08.209

    Figure Lengend Snippet: Generation of 5-FU sensitive and resistant tumors in a mouse model of chemically-induced carcinogenesis. Carcinogenesis was initiated with DMBA, followed by bi-weekly treatments with TPA to promote tumor growth. Isolated RNA from 2 pairs of 5-FU sensitive and 5-FU resistant tumors was used to perform whole-transcriptome sequencing using Illumina 2000 , in order to identify differentially expressed genes between sensitive and resistant tumors.

    Article Snippet: Two weeks after DMBA administration, we initiated treatment with 2.5 μg TPA diluted in 200 μl acetone twice a week (Sigma-Aldrich, cat. #P8139) until a mouse was sacrificed.

    Techniques: Isolation, Sequencing

    Cortical lesion volume after TBI and tPA treatment. The bar graph shows no significance (NS) in the cortical lesion volume between the TBI+Saline and TBI+tPA groups examined at 35 days post injury ( p > 0.05). Scale bar = 2 mm. Data represent mean ± SD. n = 8 (rats/group).

    Journal: PLoS ONE

    Article Title: Subacute Intranasal Administration of Tissue Plasminogen Activator Promotes Neuroplasticity and Improves Functional Recovery following Traumatic Brain Injury in Rats

    doi: 10.1371/journal.pone.0106238

    Figure Lengend Snippet: Cortical lesion volume after TBI and tPA treatment. The bar graph shows no significance (NS) in the cortical lesion volume between the TBI+Saline and TBI+tPA groups examined at 35 days post injury ( p > 0.05). Scale bar = 2 mm. Data represent mean ± SD. n = 8 (rats/group).

    Article Snippet: Sham+tPA rats (n = 8) underwent surgery without injury but received the same dose of intranasal tPA as did the TBI+tPA rats. tPA at a dose of 600 µg/rat (Genentech, San Francisco, CA) was administered intranasally at Days 7 and 14 post TBI or sham-operation.

    Techniques:

    Correlation of the total length of axons crossing the midline at the cervical spinal cord with the right forelimb foot fault (A) and the mNSS score (B). The line graph shows that the total length of axonal crossing at the midline of the cervical level of the spinal cord is significantly reversely correlated with the incidence of forelimb footfault (A) and mNSS score (B) in rats examined at 35 days after TBI and tPA treatment ( p

    Journal: PLoS ONE

    Article Title: Subacute Intranasal Administration of Tissue Plasminogen Activator Promotes Neuroplasticity and Improves Functional Recovery following Traumatic Brain Injury in Rats

    doi: 10.1371/journal.pone.0106238

    Figure Lengend Snippet: Correlation of the total length of axons crossing the midline at the cervical spinal cord with the right forelimb foot fault (A) and the mNSS score (B). The line graph shows that the total length of axonal crossing at the midline of the cervical level of the spinal cord is significantly reversely correlated with the incidence of forelimb footfault (A) and mNSS score (B) in rats examined at 35 days after TBI and tPA treatment ( p

    Article Snippet: Sham+tPA rats (n = 8) underwent surgery without injury but received the same dose of intranasal tPA as did the TBI+tPA rats. tPA at a dose of 600 µg/rat (Genentech, San Francisco, CA) was administered intranasally at Days 7 and 14 post TBI or sham-operation.

    Techniques:

    Western blot analysis of ProBDNF and mature BDNF protein levels in the brain and spinal cord. Left panel (ipsilateral brain cortex): Sham+tPA (1, 2), TBI+Saline (3, 4); 3: TBI+tPA (5, 6); Right panel (denervated cervical spinal cord): Sham+tPA (1, 2), TBI+Saline (3, 4), TBI+tPA (5, 6). * p

    Journal: PLoS ONE

    Article Title: Subacute Intranasal Administration of Tissue Plasminogen Activator Promotes Neuroplasticity and Improves Functional Recovery following Traumatic Brain Injury in Rats

    doi: 10.1371/journal.pone.0106238

    Figure Lengend Snippet: Western blot analysis of ProBDNF and mature BDNF protein levels in the brain and spinal cord. Left panel (ipsilateral brain cortex): Sham+tPA (1, 2), TBI+Saline (3, 4); 3: TBI+tPA (5, 6); Right panel (denervated cervical spinal cord): Sham+tPA (1, 2), TBI+Saline (3, 4), TBI+tPA (5, 6). * p

    Article Snippet: Sham+tPA rats (n = 8) underwent surgery without injury but received the same dose of intranasal tPA as did the TBI+tPA rats. tPA at a dose of 600 µg/rat (Genentech, San Francisco, CA) was administered intranasally at Days 7 and 14 post TBI or sham-operation.

    Techniques: Western Blot

    tPA effect on functional outcome. tPA significantly lowered the mNSS scores (A) and reduced frequency of foot faults (B) from Day 14 to 35 after TBI compared to the saline group. tPA treatment significantly improved spatial learning performance from Day 33 to 35 after TBI compared with the saline group (C). * p

    Journal: PLoS ONE

    Article Title: Subacute Intranasal Administration of Tissue Plasminogen Activator Promotes Neuroplasticity and Improves Functional Recovery following Traumatic Brain Injury in Rats

    doi: 10.1371/journal.pone.0106238

    Figure Lengend Snippet: tPA effect on functional outcome. tPA significantly lowered the mNSS scores (A) and reduced frequency of foot faults (B) from Day 14 to 35 after TBI compared to the saline group. tPA treatment significantly improved spatial learning performance from Day 33 to 35 after TBI compared with the saline group (C). * p

    Article Snippet: Sham+tPA rats (n = 8) underwent surgery without injury but received the same dose of intranasal tPA as did the TBI+tPA rats. tPA at a dose of 600 µg/rat (Genentech, San Francisco, CA) was administered intranasally at Days 7 and 14 post TBI or sham-operation.

    Techniques: Functional Assay

    tPA effect on immature neurons after TBI. DCX staining (A–C). tPA significantly increased immature neurons identified with DCX-positive staining in the DG in rats examined 35 days after injury compared with the saline-treated group. The bar graph shows the number of DCX-positive cells. Scale bar = 25 µm. * p

    Journal: PLoS ONE

    Article Title: Subacute Intranasal Administration of Tissue Plasminogen Activator Promotes Neuroplasticity and Improves Functional Recovery following Traumatic Brain Injury in Rats

    doi: 10.1371/journal.pone.0106238

    Figure Lengend Snippet: tPA effect on immature neurons after TBI. DCX staining (A–C). tPA significantly increased immature neurons identified with DCX-positive staining in the DG in rats examined 35 days after injury compared with the saline-treated group. The bar graph shows the number of DCX-positive cells. Scale bar = 25 µm. * p

    Article Snippet: Sham+tPA rats (n = 8) underwent surgery without injury but received the same dose of intranasal tPA as did the TBI+tPA rats. tPA at a dose of 600 µg/rat (Genentech, San Francisco, CA) was administered intranasally at Days 7 and 14 post TBI or sham-operation.

    Techniques: Staining

    tPA protein level and activity as well as plasmin activity in rat brain. Western blot analysis of tPA protein levels in the rat brain 24 hr after intranasal administration of tPA (A). Bar graph (B) shows the tPA protein level. Of note, Sham+tPA rats received the same amount of intranasal tPA administration as TBI+tPA rats did. Representative zymographic assay (C) shows an increase in tPA activity in the Sham+tPA rats and TBI+tPA rats compared to TBI+Saline rats. h-r-tPA: human recombinant tPA (15 ng, Genentech). Bar graph (D) shows the tPA activity. Bar graph (E) shows amidolytic activity of plasmin assayed with D-Val-Leu-Lys-p-Nitroanilide Dihydrochloride (S-2251) as its specific substrate. Bar graph (F) shows tPA amidolytic activity with S-2251 as the substrate in the presence of added plasminogen compared to Sham. * p

    Journal: PLoS ONE

    Article Title: Subacute Intranasal Administration of Tissue Plasminogen Activator Promotes Neuroplasticity and Improves Functional Recovery following Traumatic Brain Injury in Rats

    doi: 10.1371/journal.pone.0106238

    Figure Lengend Snippet: tPA protein level and activity as well as plasmin activity in rat brain. Western blot analysis of tPA protein levels in the rat brain 24 hr after intranasal administration of tPA (A). Bar graph (B) shows the tPA protein level. Of note, Sham+tPA rats received the same amount of intranasal tPA administration as TBI+tPA rats did. Representative zymographic assay (C) shows an increase in tPA activity in the Sham+tPA rats and TBI+tPA rats compared to TBI+Saline rats. h-r-tPA: human recombinant tPA (15 ng, Genentech). Bar graph (D) shows the tPA activity. Bar graph (E) shows amidolytic activity of plasmin assayed with D-Val-Leu-Lys-p-Nitroanilide Dihydrochloride (S-2251) as its specific substrate. Bar graph (F) shows tPA amidolytic activity with S-2251 as the substrate in the presence of added plasminogen compared to Sham. * p

    Article Snippet: Sham+tPA rats (n = 8) underwent surgery without injury but received the same dose of intranasal tPA as did the TBI+tPA rats. tPA at a dose of 600 µg/rat (Genentech, San Francisco, CA) was administered intranasally at Days 7 and 14 post TBI or sham-operation.

    Techniques: Activity Assay, Western Blot, Recombinant

    BDA-labeling of CST originating from the contralesional intact hemisphere. Representative images from the cervical spinal cord show BDA-labeled CST axons crossing the midline (arrows in B) and sprouting into the denervated side of the ventral gray matter in a rat after TBI. tPA treatment significantly increased the axon midline crossing (arrows in C). There were no obvious BDA-labeled axons observed in the opposite side of the cervical spinal cord in sham rats (A). Quantitative data (D) show that the number of contralesional CST in the denervated cervical gray matter was increased significantly by traumatic injury ( p

    Journal: PLoS ONE

    Article Title: Subacute Intranasal Administration of Tissue Plasminogen Activator Promotes Neuroplasticity and Improves Functional Recovery following Traumatic Brain Injury in Rats

    doi: 10.1371/journal.pone.0106238

    Figure Lengend Snippet: BDA-labeling of CST originating from the contralesional intact hemisphere. Representative images from the cervical spinal cord show BDA-labeled CST axons crossing the midline (arrows in B) and sprouting into the denervated side of the ventral gray matter in a rat after TBI. tPA treatment significantly increased the axon midline crossing (arrows in C). There were no obvious BDA-labeled axons observed in the opposite side of the cervical spinal cord in sham rats (A). Quantitative data (D) show that the number of contralesional CST in the denervated cervical gray matter was increased significantly by traumatic injury ( p

    Article Snippet: Sham+tPA rats (n = 8) underwent surgery without injury but received the same dose of intranasal tPA as did the TBI+tPA rats. tPA at a dose of 600 µg/rat (Genentech, San Francisco, CA) was administered intranasally at Days 7 and 14 post TBI or sham-operation.

    Techniques: Labeling

    tPA effect on neurogenesis after TBI. Compared to the TBI+Saline group (B), tPA treatment (C) significantly increased newborn mature neurons identified with BrdU/NeuN double immunofluorescent staining in the DG 35 days post injury. The bar graph (D) shows the number of DCX-positive cells. Scale bar = 25 µm. * p

    Journal: PLoS ONE

    Article Title: Subacute Intranasal Administration of Tissue Plasminogen Activator Promotes Neuroplasticity and Improves Functional Recovery following Traumatic Brain Injury in Rats

    doi: 10.1371/journal.pone.0106238

    Figure Lengend Snippet: tPA effect on neurogenesis after TBI. Compared to the TBI+Saline group (B), tPA treatment (C) significantly increased newborn mature neurons identified with BrdU/NeuN double immunofluorescent staining in the DG 35 days post injury. The bar graph (D) shows the number of DCX-positive cells. Scale bar = 25 µm. * p

    Article Snippet: Sham+tPA rats (n = 8) underwent surgery without injury but received the same dose of intranasal tPA as did the TBI+tPA rats. tPA at a dose of 600 µg/rat (Genentech, San Francisco, CA) was administered intranasally at Days 7 and 14 post TBI or sham-operation.

    Techniques: Staining

    Correlation of the number of neuroblasts (A), and newborn neurons (B) with spatial learning. The line graph shows that spatial learning is significantly correlated with the number of DCX-positive cells (A) and to the number of newborn mature neurons (B) in the DG of the ipsilateral hippocampus in rats examined at 35 days after TBI and tPA treatment ( p

    Journal: PLoS ONE

    Article Title: Subacute Intranasal Administration of Tissue Plasminogen Activator Promotes Neuroplasticity and Improves Functional Recovery following Traumatic Brain Injury in Rats

    doi: 10.1371/journal.pone.0106238

    Figure Lengend Snippet: Correlation of the number of neuroblasts (A), and newborn neurons (B) with spatial learning. The line graph shows that spatial learning is significantly correlated with the number of DCX-positive cells (A) and to the number of newborn mature neurons (B) in the DG of the ipsilateral hippocampus in rats examined at 35 days after TBI and tPA treatment ( p

    Article Snippet: Sham+tPA rats (n = 8) underwent surgery without injury but received the same dose of intranasal tPA as did the TBI+tPA rats. tPA at a dose of 600 µg/rat (Genentech, San Francisco, CA) was administered intranasally at Days 7 and 14 post TBI or sham-operation.

    Techniques: